levine family

Regenerative Medicine

Regenerative Medicine - The power of cord blood stem cells

"Regenerative medicine is the next evolution of medical treatments...Virtually any disease that results from malfunctioning, damaged, or failing tissues may be potentially cured..." - U.S. Department of Health and Human Services

New treatments with cord blood focus on regenerative medicine, where doctors use stem cells to repair damaged tissues and organs in the body. This emerging field of medicine is directed at treatments for conditions such as brain injury and juvenile diabetes, which have no cure today.

Reference:United States Department of Health & Human Services: 2020: A new Vision—A Future for Regenerative Medicine. Available at http://www.hhs.gov/reference/newfuture.shtml#head2. Accessed May 12, 2009.

Stem cell usage for regenerative medicine is increasing

In the past three years, CBR has released a large number of cord blood units for regenerative medicine applications to use for patients with conditions such as juvenile diabetes, traumatic brain injury and cerebral palsy. In fact, over 70% of the units released by CBR since 2005 have been for regenerative medicine and that number is steadily increasing, giving evidence to the potential of stem cells for this purpose.

Learn more about stem cells and how they are being used in regenerative medicine therapies:

  Watch: How Stem Cells Work

  Watch: What is the Potential of Cord Blood Stem Cells for Regenerative Medicine

Return to Top

Brain Injury

Along with leading medical centers, Duke University and the University of Texas, CBR has participated in groundbreaking clinical research to utilize cord blood stem cells to improve outcomes after brain injury. Circumstances of treatment include anoxic brain injury at birth, cerebral palsy, and traumatic brain injury.

Find out how stem cells are being used to improve outcomes after brain injury:

  Watch: Fox News – Cord Blood Reverses Girl's Cerebral Palsy

  Watch: How Stem Cell Therapy Can Help The Brain Repair Itself

Return to Top

Juvenile Diabetes

Research conducted at the University of Florida indicated the potential for the use of cord blood stem cells to regenerate insulin production in juvenile diabetes patients. In 2006, CBR inquired with our client population about the incidence of juvenile diabetes and a number of cases were reported. These children are now pioneers in helping to develop effective therapies for juvenile diabetes using one's own stem cells. This option is only available to these children because their parents made the decision to preserve their cord blood. We continue to advance our collaboration with the University of Florida.

Read a news article about the University of Florida's exciting study on stem cells' use in juvenile diabetes.

Reference: Haller MJ, Viener HL, Brusko T, et al. Insulin Requirements, HbA1c, and Stimulated C-peptide following Autologous Umbilical Cord Blood Transfusion in Children with T1D. Abstract presented at: Annual Meeting of the American Diabetes Association, Scientific Sessions; June 22-26, 2007 Chicago, IL.

Return to Top

Heart Disease & Conditions

In a 2005 meeting of the International Society for Stem Cell Research, Dr. Harris presented results suggesting the potential for cord blood stem cells to improve outcomes in human patients following heart attack. His data showed that in an animal model of heart attack, intracoronary delivery of cord blood stem cells increased the vascular density in the heart compared to untreated animals.

Read a news article about how cord blood stem cells may help repair babies' heart defects

Reference: Harris DT, He X, Ahmad N, et al. The potential of cord blood stem cells for tissue engineering. Poster presented at: International Society for Stem Cell Research. June 2005; San Francisco, CA. Sunkomat, JNE, S Goldman, DT Harris and MA Gaballa. Cord blood-derived MNCs delivered intracoronary contribute differently to vascularization compared to CD34+ cells in the rat model of acute ischemia. Submitted, Stem Cells, 2006. Harris, DT, H He and M Gaballa. The potential of cord blood stem cells for use in regenerative medicine of the heart. 2nd International Stem Cells Meeting, San Francisco, CA, 22-24 Jan 2007.

Return to Top

Cancer

CBR collaborated with Dr. Akita Shibata of Stanford University to utilize cord blood stem cell units and familial history profiles to isolate determinants of genetic predisposition for breast cancer, one of the leading causes of death in the female population. This research provides insight for clinicians to plan strategies for prevention, diagnosis, and treatment of this common health threat.

Reference: Shibata A, Harris DT, Billings PR. Concentrations of estrogens and IGFs in umbilical cord blood plasma: A comparison among Caucasian, Hispanic, and Asian-American Females. J Clin Endocrinol Metab. 2002;87(2):810-815.

Return to Top

Corneal Regeneration

Vision loss can occur when corneal epithelial cells are lost or are not replaced quickly enough. In data presented at the annual meeting of the International Society for Stem Cell Research, Dr. David Harris demonstrated that cord blood stem cells can differentiate into these cells and form a cell sheet that is morphologically indistinguishable from corneal epithelial cells. When transplanted in animals, cord blood stem cells improved the appearance of the corneal surface. These results suggest that cord blood could provide a future therapeutic option for individuals with disorders of the ocular surface.

Reference: Harris DT, He X, Ahmad N, et al. The potential of cord blood stem cells for tissue engineering. Poster presented at: International Society for Stem Cell Research. June 2005; San Francisco, CA. Harris, D.T., X. He, M. Badowski and JC Nichols. Regenerative Medicine of the Eye: A Short Review. In Press, Regen. Med. May 2006 Harris DT, He X, Badowski M, Nicols JC. Regenerative Medicine of the Eye: A Short Review. Stem Cell Repair & Regeneration, Vol. 3, Levicar N, Habib NA, Dimarakis I, Gordon MY (Ed.s), Imperial College Press (2007), In press.

Return to Top

New uses for cord blood stem cells are being discovered rapidly; however, banking cord blood and cord tissue does not guarantee that the cells will provide a cure or be applicable for every situation. Ultimate use will be determined by the treating physician. Use in regenerative medicine is still considered experimental. Medical treatments using cord tissue are still under development and have not yet been used in humans.

Banking cord blood does not guarantee that the cells will provide a cure or be applicable for every situation. For inherited genetic conditions, the child will not be able to use his or her own stem cells. A matched sibling's stem cells would be the first choice. Ultimate use will be determined by the treating physician. Treatment for brain injury and juvenile diabetes is experimental and currently requires the use of your own cord blood. Medical treatments using family banked cord tissue are in early research and are not available today; there is no guarantee that therapies will be developed in the future.
Share this page with family and friends: